GDTC GDTC
Company Profile ↓Company Overview
GDTC (GDTC) is a publicly traded company listed on with a market capitalization of $9.94M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.07.
Recent Developments
- Dec 2025 Revenue of $324.39K (+366.7% YoY); net profit $-3.98M.
- Trailing 12 Months Year-on-year growth — revenue +366.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 366.74% |
Stock Price Performance
| 1 Year: | -54.35% |
| 6 Months: | -1.18% |
| 3 Months: | -8.70% |
| 1 Month: | -13.40% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)37.82 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 68.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 69.50K | 324.39K |
| Cost of Revenue | - | 0 | 0 | 17.12K | 67.99K |
| Gross Profit | - | 0 | 0 | 52.38K | 256.39K |
| Operating Expenses | - | 1.86M | 3.84M | 3.18M | 4.50M |
| Operating Income | - | -1.86M | -3.84M | -3.13M | -4.24M |
| EBITDA | - | -2.61M | -3.70M | -2.17M | -3.57M |
| Interest Expense | - | 125.17K | 51.28K | 20.31K | 20.91K |
| Pretax Income | - | -3.13M | -4.13M | -2.52M | -4.00M |
| Tax Provision | - | 1.64K | 653 | 0 | 0 |
| Net Income | - | -3.13M | -4.13M | -2.52M | -3.98M |
| Diluted EPS | -0.19 | -0.29 | -0.39 | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 5.23M | 12.37M | 10.07M | 7.98M |
| Current Assets | - | 2.49M | 10.10M | 6.00M | 3.66M |
| Cash & Equivalents | - | 1.58M | 9.00M | 4.97M | 2.10M |
| Inventory | - | - | - | - | - |
| Receivables | - | - | 0 | 18.78K | 103.86K |
| Total Liabilities | - | 4.64M | 1.12M | 1.02M | 1.13M |
| Current Liabilities | - | 4.17M | 716.94K | 606.62K | 709.17K |
| Long Term Debt | - | 468.83K | 407.77K | 394.31K | 368.66K |
| Total Debt | - | 4.22M | 448.02K | 463.25K | 482.56K |
| Total Equity | - | 586.98K | 11.25M | 8.97M | 6.54M |
| Shares Outstanding | - | 10.94M | 11.53M | 11.54M | 11.83M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.40M | -3.53M | -2.71M | -3.70M |
| Investing Cash Flow | - | -473.31K | -2.73M | 1.13M | 929.28K |
| Financing Cash Flow | - | 968.72K | 10.92M | -64.89K | 208.65K |
| Capital Expenditure | - | -473.80K | -58.30K | -1.49M | -703.13K |
| Free Cash Flow | - | -1.87M | -3.59M | -4.20M | -4.40M |
| Net Change in Cash | - | -903.00K | 4.66M | -1.65M | -2.56M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | 75.4% | 79.0% |
| Operating Margin % | - | - | - | -4,504.3% | -1,307.6% |
| Net Margin % | - | - | - | -3,621.1% | -1,227.1% |
| ROE % | - | -533.4% | -36.8% | -28.1% | -60.8% |
| ROCE % | - | -174.8% | -33.0% | -33.1% | -58.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GDTC
CytoMed Therapeutics(GDTC) Stock Options Chain | Quotes & News - Moomoo
<a href="https://news.google.com/rss/articles/CBMitgJBVV95cUxOc25BUm5OMjkyVWVaamV3QU84MVZ1YTFzeHF0cVRlZXlrME52M3ltcXpqN2JaU1FtZ2N2QUY5QWZPMnBVTlo0ZDlFMGF3SGNJMWVNZjBFNXRKQTFIcVBWRXRtTlMxZ0trRlpCV2tZcWV3bEpQMWVpV3BTMzJYV2dPdGprZW85eXMwZ0YySn…
CytoMed Therapeutics (GDTC) insider discloses two ordinary share dispositions - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNYks3d2lPRDNuejYwbUxTQnhzT0d6QlREbXBTUjk2TkllZHVYNW5DWnhLUDNaclNpMFJZaWNhUFdiV0JsYzQzdzd1bEU5R085clpsd0JmMjBoN2NhdHI1djgxMTdvUzk2RTZ1MVUxNTBWZ1dUOS1XUVRNOER5YWx2dF9WczVRZ3lCNU1kLX…
GDTC|CytoMed Therapeutics Ltd|Price:0.960|Chg%:+0.030 - TradingKey
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBhdjVQQW9lRW9pbUE2d09hU2NkRHNVZFQ1SmFJVUZNLTh4aktVaFJSVzlEMXBwaW9QRUdkTnRyLVE0UjNUQ2h4cERnZHJmbEF6MDEwcXA0OWU1UQ?oc=5" target="_blank">GDTC|CytoMed Therapeutics Ltd|Price:0.960|Chg…
CytoMed Therapeutics' US$1.7m Market Cap Fall Books Insider Losses - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxPRjJEaEc2dE52LWZpMkMwVVYxM1pFVDdxRTVuUzlmc0E2aklYZ2h5T0xDcXA0UjFRWktEWDRMTlNxR3ZIZzZuNDI0VUZxbGs0Zy1MQndRTGZZMzVKanNqUXdiei1CTHZ1NFNIU3k5Y2MxV1hTcVdEM05MSnpGdURfdnc4VlRyT0QxUjJCdX…
Insider Stock Purchases: July 24, 2026 - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQcW4yS1hJempQUlEtQ3B2TElCOURlMzd6TzhQUGlmR1R4SUlDWEVrWXd5c1hUT3dDeHRCNTkwX2I1QnU2aEpMZHktczhFNnoxaFQxMEVwazRwX3FjRmE1Z0Zhd3lUb1g0MWhKVEdBZzQzRzZoYl8wWnZZb0l2UmRuRw?oc=5" target="_…
CytoMed Therapeutics (GDTC) director adds 200,000 shares in July buys - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPeUtsYkt2NGFRMS1oMXhSdk1pTk1kQWJodHNBWlhxZGxjcWc1YUFQdGxWaVQ2bGkxRnV0WE93VGxVN1VxN3AzV3ZvbzU2WkJuSEVBU0RiejBrWjB5TmxNenctQng5bExyMjdUM1VBWkppQ0YySU5FcWJManlKQmplT1ZWV2h0Wnk5WHdxaD…
GDTC — Frequently Asked Questions
What is the current share price of GDTC?
As of 2026-08-05 17:25 PDT, GDTC trades at $0.84 on NASDAQ/NYSE. Its 52-week range is $0.72 to $2.69.
What is the market capitalisation of GDTC?
GDTC has a market capitalisation of $9.94M on NASDAQ/NYSE.
What is the P/E ratio of GDTC?
GDTC trades at a trailing price-to-earnings (P/E) ratio of -2.15. Its price-to-book (P/B) ratio is 1.52.
What is the return on equity (ROE) of GDTC?
GDTC has a return on equity (ROE) of -60.82%. Its return on capital employed (ROCE) is -58.30%.
Is GDTC a good stock to buy?
This page provides a data-driven analysis of GDTC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.